These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37614820)

  • 1. Case report: Progressive pulmonary artery hypertension in a case of megalencephaly-capillary malformation syndrome.
    Yoh Y; Shiohama T; Uchida T; Ebata R; Kobayashi H; Okunushi K; Kato M; Watanabe K; Nakashima M; Saitsu H; Hamada H
    Front Genet; 2023; 14():1221745. PubMed ID: 37614820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP.
    Mirzaa GM; Rivière JB; Dobyns WB
    Am J Med Genet C Semin Med Genet; 2013 May; 163C(2):122-30. PubMed ID: 23592320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden death in a case of megalencephaly capillary malformation associated with a de novo mutation in AKT3.
    Harada A; Miya F; Utsunomiya H; Kato M; Yamanaka T; Tsunoda T; Kosaki K; Kanemura Y; Yamasaki M
    Childs Nerv Syst; 2015 Mar; 31(3):465-71. PubMed ID: 25416470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of cerebrospinal fluid-derived cell-free DNA in molecular diagnostics for the
    Chen WL; Pao E; Owens J; Glass I; Pritchard C; Shirts BH; Lockwood C; Mirzaa GM
    Cold Spring Harb Mol Case Stud; 2022 Apr; 8(3):. PubMed ID: 35483878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS).
    Ranieri C; Di Tommaso S; Loconte DC; Grossi V; Sanese P; Bagnulo R; Susca FC; Forte G; Peserico A; De Luisi A; Bartuli A; Selicorni A; Melis D; Lerone M; Praticò AD; Abbadessa G; Yu Y; Schwartz B; Ruggieri M; Simone C; Resta N
    Neurogenetics; 2018 May; 19(2):77-91. PubMed ID: 29549527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline PTPN11 and somatic PIK3CA variant in a boy with megalencephaly-capillary malformation syndrome (MCAP)--pure coincidence?
    Döcker D; Schubach M; Menzel M; Spaich C; Gabriel HD; Zenker M; Bartholdi D; Biskup S
    Eur J Hum Genet; 2015 Mar; 23(3):409-12. PubMed ID: 24939587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autism spectrum disorder in a child with megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP).
    St John LJ; Rao N
    BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34969807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe holocord syrinx in a child with megalencephaly-capillary malformation syndrome.
    Segal D; Heary RF; Sabharwal S; Barry MT; Ming X
    J Neurosurg Pediatr; 2016 Jul; 18(1):79-82. PubMed ID: 27035547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megalencephaly-Capillary Malformation-Polymicrogyria Syndrome (MCAP): A Rare Dynamic Genetic Disorder.
    Sarma K; Nayak MK; Mishra B; Gaikwad SB
    Cureus; 2022 May; 14(5):e25123. PubMed ID: 35733479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis.
    Mirzaa GM; Conway RL; Gripp KW; Lerman-Sagie T; Siegel DH; deVries LS; Lev D; Kramer N; Hopkins E; Graham JM; Dobyns WB
    Am J Med Genet A; 2012 Feb; 158A(2):269-91. PubMed ID: 22228622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megalencephaly-Capillary Malformation-Polymicrogyria with Cerebral Venous Thrombosis.
    Fortin O; Ashour M; Lacroix C; Sabapathy CA; Myers KA
    Can J Neurol Sci; 2020 Nov; 47(6):828-829. PubMed ID: 32631464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed analysis of phenotypes and genotypes in megalencephaly-capillary malformation-polymicrogyria syndrome caused by somatic mosaicism of PIK3CA mutations.
    Park HJ; Shin CH; Yoo WJ; Cho TJ; Kim MJ; Seong MW; Park SS; Lee JH; Sim NS; Ko JM
    Orphanet J Rare Dis; 2020 Aug; 15(1):205. PubMed ID: 32778138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PIK3CA-related overgrowth syndrome (PROS)].
    Venot Q; Canaud G
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S155-S156. PubMed ID: 28577738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Molecular Spectrum of Sporadic Vascular Malformations: A Single-Center Study.
    Diociaiuti A; Rotunno R; Pisaneschi E; Cesario C; Carnevale C; Condorelli AG; Rollo M; Di Cecca S; Quintarelli C; Novelli A; Zambruno G; El Hachem M
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone deficiency in megalencephaly-capillary malformation syndrome: An association with activating mutations in PIK3CA.
    Davis S; Ware MA; Zeiger J; Deardorff MA; Grand K; Grimberg A; Hsu S; Kelsey M; Majidi S; Matthew RP; Napier M; Nokoff N; Prasad C; Riggs AC; McKinnon ML; Mirzaa G
    Am J Med Genet A; 2020 Jan; 182(1):162-168. PubMed ID: 31729162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One of the First Cases with PIK3CA-related Overgrowth Spectrum (PROS) in Saudi Arabia: A Case Report and Literature Review.
    Alsaedi SA; Qurashi O; Bajunaid M; Altalhi AA; Shawli AM
    Cureus; 2020 Jan; 12(1):e6586. PubMed ID: 31929958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and neuroimaging findings in 33 patients with MCAP syndrome: A survey to evaluate relevant endpoints for future clinical trials.
    Garde A; Guibaud L; Goldenberg A; Petit F; Dard R; Roume J; Mazereeuw-Hautier J; Chassaing N; Lacombe D; Morice-Picard F; Toutain A; Arpin S; Boccara O; Touraine R; Blanchet P; Coubes C; Willems M; Pinson L; Van Kien PK; Chiaverini C; Giuliano F; Alessandri JL; Mathieu-Dramard M; Morin G; Bursztejn AC; Mignot C; Doummar D; Di Rocco F; Cornaton J; Nicolas C; Gautier E; Luu M; Bardou M; Sorlin A; Philippe C; Edery P; Rossi M; Carmignac V; Thauvin-Robinet C; Vabres P; Faivre L
    Clin Genet; 2021 May; 99(5):650-661. PubMed ID: 33415748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymicrogyria in association with hypoglycemia points to mutation in the mTOR pathway.
    Stutterd C; McGillivray G; Stark Z; Messazos B; Cameron F; White S; ; Mirzaa G; Leventer R
    Eur J Med Genet; 2018 Dec; 61(12):738-740. PubMed ID: 29883676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors.
    Loconte DC; Grossi V; Bozzao C; Forte G; Bagnulo R; Stella A; Lastella P; Cutrone M; Benedicenti F; Susca FC; Patruno M; Varvara D; Germani A; Chessa L; Laforgia N; Tenconi R; Simone C; Resta N
    PLoS One; 2015; 10(4):e0123092. PubMed ID: 25915946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pitfalls in the diagnosis of segmental overgrowth syndromes: a child with the c.2740G > A mutation in PIK3CA gene.
    Maguolo A; Antoniazzi F; Spano A; Fiorini E; Gaudino R; Mauro M; Cantalupo G; Biban P; Maitz S; Cavarzere P
    Ital J Pediatr; 2018 Sep; 44(1):110. PubMed ID: 30231930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.